Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel
Condition(s):Transitional Cell CarcinomaLast Updated:December 4, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Transitional Cell CarcinomaLast Updated:December 4, 2018Completed
Condition(s):Secondary Angiosarcoma; Locally Advanced Sarcoma; MetastasisLast Updated:February 3, 2022Recruiting
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:March 16, 2023Recruiting
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:September 5, 2021Terminated
Condition(s):Plasma Cell Leukemia; Multiple MyelomaLast Updated:September 22, 2011Unknown status
Condition(s):Waldenstrom’s MacroglobulinemiaLast Updated:January 28, 2021Completed
Condition(s):Head and Neck CancerLast Updated:January 12, 2018Terminated
Condition(s):Gastrointestinal Stromal TumorsLast Updated:March 19, 2021Completed
Condition(s):Relapsed and/or Refractory Cutaneous T-cell LymphomaLast Updated:October 26, 2020Completed
Condition(s):Acute Myeloid Leukaemia RecurrentLast Updated:February 24, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.